GHK-Cu should typically be applied first, directly to clean scalp
G., Enzmann, H., Pate, I., and Waechter, F
Approved uses : The Food and Drug Administration (FDA) has approved Jardiance and Farxiga for: Reducing the risk of heart-related death and hospitalization in adults with heart failure Decreasing the risk of declining kidney function, end-stage kidney disease, heart-related death, and hospitalization in adults with chronic kidney disease (CKD) at risk of progression Improving glycemic control in adults with type 2 diabetes as part of a diet and exercise plan Jardiance also reduces the risk of heart-related death in adults with type 2 diabetes and established heart disease
In March 2026, the TRANSCEND-T2D-1 trial showed retatrutide delivered up to 2.0% A1C reduction and nearly 17% weight loss at 40 weeks with no plateau observed, meaning participants were still losing weight at the end of the trial
MT-2 is not FDA-approved
Taking the injection on Monday means hunger returns by Friday